Reut Ramon-Saraf

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children.

J. Shiloach, R. Schneerson, J. Robbins, 2010, Vaccine.

Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.

E. Vinogradov, R. Schneerson, J. Robbins, 2017, Vaccine.